Regulon

Regulon: R-1516

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
211.8080810Pr-138Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
25937 ENSG00000018408 WWTR1 Q9GZV5
10908 ENSG00000032444 PNPLA6 Q8IY17
8301 ENSG00000073921 PICALM Q13492
51586 ENSG00000099917 MED15 Q96RN5
9647 ENSG00000100034 PPM1F P49593
215 ENSG00000101986 ABCD1 P33897
23064 ENSG00000107290 SETX Q7Z333
9749 ENSG00000112419 PHACTR2 O75167
6249 ENSG00000130779 CLIP1 A0A024RBR1
90627 ENSG00000133121 STARD13 Q9Y3M8
9320 ENSG00000153827 TRIP12 Q14669
55361 ENSG00000155252 PI4K2A Q9BTU6
23367 ENSG00000155506 LARP1 Q6PKG0
476 ENSG00000163399 ATP1A1 P05023
23132 ENSG00000164080 RAD54L2 Q9Y4B4
3916 ENSG00000185896 LAMP1 P11279
9931 ENSG00000198265 HELZ P42694
50618 ENSG00000198399 ITSN2 Q9NZM3
1500 ENSG00000198561 CTNND1 O60716
4363 ENSG00000278183 ABCC1 A0A0A0MS99
22877 ENSG00000281178 MLXIP Q9HAP2

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
LANATOSIDE CATP1A1Small moleculeINHIBITORSodium/potassium-transporting ATPase inhibitor40
DIGOXINATP1A1Small moleculeINHIBITORSodium/potassium-transporting ATPase inhibitor40
ACETYLDIGITOXINATP1A1Small moleculeINHIBITORSodium/potassium-transporting ATPase inhibitor40
DIGITOXINATP1A1Small moleculeINHIBITORSodium/potassium-transporting ATPase inhibitor40
DESLANOSIDEATP1A1Small moleculeINHIBITORSodium/potassium-transporting ATPase inhibitor40
ISTAROXIMEATP1A1Small moleculeINHIBITORSodium/potassium-transporting ATPase inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1516

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs